Plasma Therapy Market Size, Share, Trends, Growth Outlook

Plasma Therapy Market is estimated to increase at a Compounded Annual Growth Rate of 13.2% CAGR over the forecast period from 2024 to 2030

The Plasma Therapy Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Pure Platelet-rich plasma (PRP), Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), By Application (Orthopedics, Dermatology, Dentistry, Others), By End-User (Hospitals, Dermatology Clinics, Others).

An Introduction to Plasma Therapy Market in 2024

Plasma therapy, also known as convalescent plasma therapy, involves using plasma obtained from individuals who have recovered from a particular disease to treat those who are currently infected or at risk of infection. In 2024, the market for plasma therapy continues to evolve, driven by ongoing research into its efficacy for various infectious diseases, including viral infections such as COVID-19, Ebola, and influenza, as well as emerging pathogens with pandemic potential. Plasma therapy relies on the presence of antibodies and other immune factors in the donor plasma, which can help boost the recipient's immune response and reduce the severity of illness or prevent infection altogether. With advancements in blood banking technology, plasma collection, and processing techniques, plasma therapy offers a promising treatment option for infectious diseases, particularly in situations where specific antiviral medications or vaccines are not available or are limited in efficacy. Moreover, the development of standardized protocols, clinical guidelines, and regulatory frameworks for plasma therapy enhances its accessibility, safety, and effectiveness in clinical practice. As the global healthcare community continues to combat infectious disease outbreaks and pandemics, plasma therapy plays a critical role in expanding treatment options, reducing morbidity and mortality, and improving public health outcomes.

Market Trend: Increased Adoption for COVID-19 Treatment

A significant market trend in plasma therapy is its increased adoption for the treatment of COVID-19 patients, driven by the urgent need for effective treatments during the pandemic. Convalescent plasma, rich in antibodies against the SARS-CoV-2 virus, has been used as a therapeutic intervention to boost the immune response and reduce the severity of COVID-19 symptoms in infected individuals. This trend reflects a strategic response to the global health crisis, with healthcare providers and policymakers leveraging plasma therapy as a potential treatment option to mitigate the impact of COVID-19 on public health systems and improve patient outcomes.

Market Driver: Growing Interest in Immunotherapy and Regenerative Medicine

A primary driver fueling the growth of the plasma therapy market is the growing interest in immunotherapy and regenerative medicine approaches for treating a wide range of diseases and medical conditions. Plasma therapy harnesses the therapeutic potential of plasma-derived proteins, growth factors, and cytokines to modulate immune responses, promote tissue regeneration, and restore physiological balance in patients with autoimmune disorders, chronic wounds, and degenerative conditions. The expanding applications of plasma therapy in oncology, dermatology, orthopedics, and wound care underscore its versatility and potential as a promising treatment modality in the field of regenerative medicine, driving investments in research, clinical trials, and commercialization efforts to advance plasma-based therapies and expand their clinical utility.

Market Opportunity: Development of Next-Generation Plasma Products

An enticing opportunity within the plasma therapy market lies in the development of next-generation plasma products with enhanced efficacy, safety, and scalability for diverse therapeutic indications. By leveraging advances in plasma fractionation techniques, purification technologies, and bioprocessing methods, researchers and manufacturers can isolate and concentrate specific plasma components, such as monoclonal antibodies, growth factors, and extracellular vesicles, to create novel plasma-derived therapeutics with targeted mechanisms of action and improved clinical outcomes. Furthermore, the development of recombinant plasma proteins and plasma-based biologics offers opportunities to overcome limitations associated with donor variability, pathogen transmission risks, and supply chain constraints inherent in traditional plasma-derived products, unlocking new possibilities for personalized medicine and precision therapeutics in a wide range of therapeutic areas. Collaborations between academic researchers, biotechnology companies, and plasma fractionation facilities can drive innovation in next-generation plasma products, accelerating the translation of scientific discoveries into clinically impactful treatments and addressing unmet medical needs in patient care.

Plasma Therapy Market Share Analysis: Pure Platelet-Rich Plasma (PRP) is the fastest growing segment over the forecast period to 2030

Among the provided segments, Pure Platelet-Rich Plasma (PRP) is the fastest growing in the Plasma Therapy Market. This growth can be attributed to several factors. Firstly, Pure PRP therapy has gained significant attention and acceptance in various medical specialties, particularly orthopedics and dermatology, due to its regenerative properties and potential benefits in tissue repair and wound healing. Additionally, advancements in processing techniques and standardization of PRP preparation protocols have improved the efficacy and consistency of Pure PRP formulations, enhancing its therapeutic potential. Furthermore, the increasing prevalence of musculoskeletal disorders such as osteoarthritis and sports injuries, along with the rising demand for minimally invasive treatment options, drive the adoption of Pure PRP therapy in orthopedics. Moreover, the growing awareness of cosmetic procedures and the desire for non-surgical solutions for skin rejuvenation and hair restoration fuel the demand for Pure PRP therapy in dermatology. As a result, Pure Platelet-Rich Plasma (PRP) emerges as the fastest growing segment in the Plasma Therapy Market, catering to the needs of hospitals, dermatology clinics, and other healthcare facilities effectively.

Plasma Therapy Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossArthrex Inc, Exactech Inc, Johnson & Johnson, MTF Biologics, Ony Biotech Inc, Pfizer Inc, Regen Lab SA, Terumo Corp, Teva Pharmaceutical Industries Ltd, Zimmer Biomet Holdings Inc

Plasma Therapy Market Segmentation

By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Plasma Therapy Market Companies

Arthrex Inc
Exactech Inc
Johnson & Johnson
MTF Biologics
Ony Biotech Inc
Pfizer Inc
Regen Lab SA
Terumo Corp
Teva Pharmaceutical Industries Ltd
Zimmer Biomet Holdings Inc

Reasons to Buy the Plasma Therapy Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Plasma Therapy Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Plasma Therapy Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Plasma Therapy Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Plasma Therapy Market Size Outlook, $ Million, 2021 to 2030
3.2 Plasma Therapy Market Outlook by Type, $ Million, 2021 to 2030
3.3 Plasma Therapy Market Outlook by Product, $ Million, 2021 to 2030
3.4 Plasma Therapy Market Outlook by Application, $ Million, 2021 to 2030
3.5 Plasma Therapy Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Plasma Therapy Industry
4.2 Key Market Trends in Plasma Therapy Industry
4.3 Potential Opportunities in Plasma Therapy Industry
4.4 Key Challenges in Plasma Therapy Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Plasma Therapy Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Plasma Therapy Market Outlook by Segments
7.1 Plasma Therapy Market Outlook by Segments, $ Million, 2021- 2030
By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others

8 North America Plasma Therapy Market Analysis and Outlook To 2030
8.1 Introduction to North America Plasma Therapy Markets in 2024
8.2 North America Plasma Therapy Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Plasma Therapy Market size Outlook by Segments, 2021-2030
By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others

9 Europe Plasma Therapy Market Analysis and Outlook To 2030
9.1 Introduction to Europe Plasma Therapy Markets in 2024
9.2 Europe Plasma Therapy Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Plasma Therapy Market Size Outlook by Segments, 2021-2030
By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others

10 Asia Pacific Plasma Therapy Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Plasma Therapy Markets in 2024
10.2 Asia Pacific Plasma Therapy Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Plasma Therapy Market size Outlook by Segments, 2021-2030
By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others

11 South America Plasma Therapy Market Analysis and Outlook To 2030
11.1 Introduction to South America Plasma Therapy Markets in 2024
11.2 South America Plasma Therapy Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Plasma Therapy Market size Outlook by Segments, 2021-2030
By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others
12 Middle East and Africa Plasma Therapy Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Plasma Therapy Markets in 2024
12.2 Middle East and Africa Plasma Therapy Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Plasma Therapy Market size Outlook by Segments, 2021-2030
By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Arthrex Inc
Exactech Inc
Johnson & Johnson
MTF Biologics
Ony Biotech Inc
Pfizer Inc
Regen Lab SA
Terumo Corp
Teva Pharmaceutical Industries Ltd
Zimmer Biomet Holdings Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Pure Platelet-rich plasma (PRP)
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Application
Orthopedics
Dermatology
Dentistry
Others
By End-User
Hospitals
Dermatology Clinics
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)